weightloss.com.au
weightloss.com.au
Contrave logoContrave
vs
Ozempic logoOzempic

Contrave vs Ozempic

Contrave and Ozempic represent two fundamentally different approaches to weight loss medication in Australia. Contrave is a daily oral tablet combining naltrexone and bupropion that targets brain reward pathways, producing ~5-8% weight loss. Ozempic is a weekly GLP-1 injection that achieves ~15% weight loss but is only PBS-subsidised for diabetes.

Contrave: ~5-8% avg. loss
Ozempic: ~15% avg. loss
Contrave cost: $150-200 private
Ozempic cost: $32 PBS / $134 private

Compare Contrave vs Ozempic at a Glance

 ContraveOzempic
Drug classOpioid antagonist + NDRI combinationGLP-1 receptor agonist
How takenDaily oral tabletsWeekly injection
Avg. weight loss~5-8%~15%
First approved2014 (FDA), 2019 (TGA)2017 (FDA), 2019 (TGA)
AU cost/month$150-200 private$32 PBS / $134 private
PBS statusNoYes (diabetes only)
Prescription needed?YesYes
AU supply statusNo issuesConstrained (improving)

Compare Contrave vs Ozempic Cost in Australia

Contrave: $150-200 private

Ozempic: $32 PBS / $134 private (PBS: Yes (diabetes only))

Compare Contrave vs Ozempic Weight Loss Efficacy

Contrave Clinical Trials

COR-I

6.1% weight loss vs 1.3% placebo

56 weeksn=1,742

COR-II

6.4% weight loss maintained

56 weeks

COR-BMOD

9.3% with intensive behaviour modification

56 weeks

Ozempic Clinical Trials

SUSTAIN 1-12

5-7kg weight loss (diabetes population)

30-104 weeks

STEP 1 (higher dose)

14.9% body weight reduction

68 weeks

Clinical trial data at highest approved doses. Individual results vary.

Compare Contrave vs Ozempic Side Effects

Contrave

Very common

  • Nausea (32%)
  • Constipation (18%)
  • Headache (14%)

Common

  • Vomiting
  • Dizziness
  • Insomnia
  • Dry mouth
  • Diarrhoea

Serious (rare)

  • Seizures (contraindicated in seizure disorders)
  • Increased blood pressure
  • Hepatotoxicity
  • Suicidal thoughts (bupropion, young adults)
  • Cannot be used with opioids

Ozempic

Very common

  • Nausea (20-44%)
  • Diarrhoea (8-30%)
  • Vomiting

Common

  • Constipation
  • Abdominal pain
  • Headache
  • Fatigue
  • Injection site reactions

Serious (rare)

  • Pancreatitis
  • Gallbladder problems
  • Kidney injury
  • Thyroid tumours (animal studies)
  • Suicidal ideation (under investigation)

Compare How Contrave and Ozempic Work

Contrave

Opioid antagonist + NDRI combination

Targets two brain pathways. Naltrexone (opioid antagonist) blocks reward/craving pathways in the mesolimbic dopamine circuit. Bupropion (NDRI) acts on the hypothalamic appetite centre to reduce hunger. The combination addresses both biological hunger drive and reward-based food cravings.

Ozempic

GLP-1 receptor agonist

Mimics the natural hormone GLP-1. Slows gastric emptying, increases insulin production, reduces glucagon, and acts on appetite centres in the brain to reduce hunger. Once-weekly injection in abdomen, thigh, or upper arm.

Compare Contrave vs Ozempic Dosing Schedule

Contrave

Daily oral tablets

DosePeriodNote
1 tab morningWeek 1Starting dose
1 AM + 1 PMWeek 2Escalation
2 AM + 1 PMWeek 3Escalation
2 AM + 2 PMWeek 4+Maintenance (4 tablets/day)

Ozempic

Weekly subcutaneous injection

DosePeriodNote
0.25mgWeeks 1-4Starting dose
0.5mgWeeks 5-8Dose escalation
1mgWeek 9+Maintenance dose

Compare Contrave vs Ozempic Australian Regulatory Status

Contrave

TGA StatusRegistered on ARTG for chronic weight management
PBS ListedNo PBS listing
Supply StatusNo supply issues
Key AdvantageOnly combination oral weight loss drug in AU; no injections needed
UK NameMarketed as Mysimba in the UK

Ozempic

TGA StatusRegistered on ARTG for type 2 diabetes
PBS ListedYes, for type 2 diabetes (Authority Required)
Off-label UseRestricted since Oct 2024 for new weight loss prescriptions
Supply StatusOngoing shortage since 2022; improving but not resolved
CompoundingCompounded versions banned from 1 October 2024

Full Contrave profile

View Contrave Details

Full Ozempic profile

View Ozempic Details

Compare Other Medications

View all weight loss medications

This website is for informational and research purposes only. We are not medical professionals and nothing on this page constitutes medical advice, diagnosis, or treatment. Always consult a qualified doctor or specialist before making any decisions about medication.

The weight loss medication landscape in Australia is changing rapidly. Information on this page may become outdated without notice. Data sourced from the TGA, FDA, MHRA, NICE, PBAC, Australian Prescriber, Obesity Evidence Hub, and clinical trial publications. Last reviewed March 2026.